Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

New research shows that in people with high blood pressure as part of metabolic syndrome, a cluster of conditions that increases the risk for heart disease, diuretics offer greater protection against cardiovascular disease, including heart failure, and are at least as effective for lowering blood pressure as newer, more expensive medications.

28 Jan 2008

Hawthorn extract helps the heart

Taking hawthorn extract can help control symptoms of chronic heart disease such as low abilities to work and walk, and also improve a range of heart-related measurements.

24 Jan 2008

Simplified scoring system may predict overall CVD risk

Physicians currently evaluate a patient's risk for heart disease, stroke and other cardiovascular diseases (CVD) individually, but a new assessment tool could gauge risk of overall 'or global' CVD and a range of cardiovascular diseases at one time, according to a study published in Circulation: Journal of the American Heart Association.

23 Jan 2008

National study will look at German-made heart pump for children needing heart transplants

Texas Children's Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD).

21 Jan 2008

Immune modulation therapy can help heal patients with heart failure

Modifying the immune system of a patient with heart failure reduces the patient's risk of death and the need for hospitalization, according to research published in The Lancet.

21 Jan 2008

Fish oil supplements may help some cardiac patients while harming others

Fish oil supplements may help some cardiac patients while harming others, suggests a new review of evidence compiled by St. Michael's Hospital and University of Toronto researchers.

15 Jan 2008

University of Minnesota researchers have created a beating heart in the laboratory

By using a process called whole organ decellularization, scientists from the University of Minnesota Center for Cardiovascular Repair grew functioning heart tissue by taking dead rat and pig hearts and reseeding them with a mixture of live cells. The research will be published online in the January 13 issue of Nature Medicine.

15 Jan 2008

Short periods of stress help condition heart to survive major attack

People who experience brief periods of blocked blood flow may be better conditioned to survive a full-blown heart attack later, according to new research from the University of Cincinnati (UC).

8 Jan 2008

Vitamin D deficiency linked to increased risk of cardiovascular disease

The same vitamin D deficiency that can result in weak bones now has been associated with an increased risk of cardiovascular disease, Framingham Heart Study researchers report in Circulation: Journal of the American Heart Association.

8 Jan 2008

Congestive heart failure leads to greater disability, nursing home admissions

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer.

8 Jan 2008

Low blood levels of vitamin D linked to heart attacks and strokes

According to new research people who have low levels of vitamin D in their blood are at an increased risk for heart attack, heart failure and stroke.

7 Jan 2008

Congestive heart failure leads to greater disability among older adults

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer. But as their hearts decline into congestive heart failure, an increasing number will experience disability and the need for nursing-home care.

7 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

Experimental IT to reduce medication errors under study

Medication errors are one of the most serious problems occurring in doctor's offices and out-patient clinics, and older persons with chronic conditions are the most vulnerable.

4 Jan 2008

Patient with AIDS finds heart-assit device is an option when transplant is not

Josh Bristow was in the late stages of heart failure when he came to the Emergency Department at Cedars-Sinai Medical Center on Aug. 25, 2007.

28 Dec 2007

Health coverage improves health and reduces major heart complications

As presidential candidates ramp up their primary campaigns, health care reform looms prominently among voters' main concerns.

28 Dec 2007

Cardiac stem cell therapy research

Since the year 2000, much has been learned about the potential for using transplanted cells in therapeutic efforts to treat varieties of cardiac disorders.

28 Dec 2007

Colon cancer screenings may bring little benefit and may actually pose harm

Even though current guidelines advocate colorectal cancer screenings for those with severe illnesses, they may bring little benefit and may actually pose harm, according to a recent study by Yale School of Medicine researchers published in the Archives of Internal Medicine.

20 Dec 2007

Genetic cause of Kawasaki disease

Researchers from Japan's RIKEN SNP Research Center, collaborating with a team at the University of California, San Diego (UCSD), have discovered a new genetic variation that affects a child's risk of getting Kawasaki disease (KD), an illness characterized by acute inflammation of the arteries throughout the body.

17 Dec 2007

Sunitinib may be associated with cardiac toxicity

Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).

17 Dec 2007